We then evaluated an RNA-Seq cohort of 51 MCC tumor biopsies to examine the association between class I genes and the chromatin-modifying complexes (PRC1.1, PRC2, and ST-MYCL-EP400) implicated by our screen hits. This evidence concerns the gene EP400 and Merkel cell skin cancer.